Grant Award Details
To develop: 1) CD133-enriched multi-potent cGMP isolated hF-NSC lines tested in vitro and in vivo; 2) An in vitro profile with predictive value for in vivo efficacy.
Grant Application Details
- Generation and in vitro profiling of neural stem cell lines to predict in vivo efficacy for chronic cervical spinal cord injury.
This project generates new cGMP compliant tissue educated human neural stem cell lines, paired with in vivo pre-clinical proof of concept testing, and development of a predictive in vitro profile.
Identification of new cell lines with in vivo efficacy testing to enable efficient translation to chronic cervical spinal cord injury, an area of significant unmet medical need.
Major Proposed Activities
- Derivation of new human neural stem cell lines
- In vitro characterization of human neural stem cell lines
- Construction of an in vitro cell line profile that can discriminate in vivo efficacy potential
- In vivo analysis of human neural stem cell line efficacy after transplantation into spinal cord injured mice
The impact of this research includes generation of new CD133-enriched tissue-educated cGMP compliant human neural stem cell lines, which have demonstrated capacity for translation into the clinical for multiple neurological disorders, and development of a profile that can relate in vitro expression analyses from these cells under growth and differentiation conditions to in vivo efficacy. Both of these are critical steps for effective translation.